We are live on
!
Find out more
Axa Portfolio holdings
AUM
$91.9M
1-Year Est. Return
27.41%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.86% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.33% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
PENN Entertainment
PENN
$2.38B
| $1.42M | ﹤0.01% |
+33,400
| New | +$1.53M |
|
852
Moog Inc Class A
MOG.A
$11.3B
| $1.41M | ﹤0.01% |
16,100
-2,800
| -15% | -$227K |
|
853
Vanguard World Funds Extended Duration ETF
EDV
$3.66B
| $1.41M | ﹤0.01% |
11,613
+8,527
| +276% | +$1.09M |
|
|
TRUE
854
DELISTED
TrueCar
TRUE
| $1.41M | ﹤0.01% |
357,100
-10,800
| -3% | -$38.2K |
|
855
Avantor
AVTR
$10.4B
| $1.4M | ﹤0.01% |
41,300
-24,100
| -37% | -$860K |
|
856
Cinemark Holdings
CNK
$3.93B
| $1.39M | ﹤0.01% |
80,600
-1,800
| -2% | -$29.9K |
|
|
HR
857
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.39M | ﹤0.01% |
50,656
| – | – |
|
858
Rush Enterprises Class A
RUSHA
$5.75B
| $1.39M | ﹤0.01% |
61,425
-13,500
| -18% | -$316K |
|
859
Criteo S.A.
CRTO
$837M
| $1.38M | ﹤0.01% |
50,800
-1,000
| -2% | -$31.8K |
|
|
CCRN
860
DELISTED
Cross Country Healthcare
CCRN
| $1.37M | ﹤0.01% |
63,100
+50,000
| +382% | +$1.08M |
|
861
Manhattan Associates
MANH
$12.2B
| $1.36M | ﹤0.01% |
9,800
-400
| -4% | -$53.6K |
|
862
First Financial Bankshares
FFIN
$4.82B
| $1.36M | ﹤0.01% |
30,800
-1,000
| -3% | -$47.8K |
|
863
GoPro
GPRO
$272M
| $1.34M | ﹤0.01% |
157,200
-10,400
| -6% | -$92.2K |
|
864
Buckle
BKE
$2.04B
| $1.33M | ﹤0.01% |
40,400
-700
| -2% | -$25.9K |
|
865
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.72B
| $1.33M | ﹤0.01% |
30,265
+220
| +0.7% | +$9.74K |
|
|
THR
866
DELISTED
Thermon Group Holdings
THR
| $1.33M | ﹤0.01% |
+82,100
| New | +$1.43M |
|
867
American Financial Group
AFG
$11.9B
| $1.32M | ﹤0.01% |
9,073
-48
| -0.5% | -$6.55K |
|
|
AXDX
868
DELISTED
Accelerate Diagnostics
AXDX
| $1.32M | ﹤0.01% |
91,351
-43,251
| -32% | -$1.23M |
|
869
Stanley Black & Decker
SWK
$13.4B
| $1.31M | ﹤0.01% |
9,391
-4,100
| -30% | -$677K |
|
870
Prothena Corp
PRTA
$428M
| $1.28M | ﹤0.01% |
+35,100
| New | +$1.27M |
|
871
Abercrombie & Fitch
ANF
$5.74B
| $1.28M | ﹤0.01% |
39,900
-11,300
| -22% | -$392K |
|
872
Reliance Steel & Aluminium
RS
$20B
| $1.25M | ﹤0.01% |
+6,800
| New | +$1.18M |
|
873
Fluor
FLR
$7.23B
| $1.25M | ﹤0.01% |
43,400
-4,200
| -9% | -$101K |
|
874
BrightView Holdings
BV
$1.01B
| $1.24M | ﹤0.01% |
91,000
-15,600
| -15% | -$211K |
|
875
Timken Company
TKR
$8.08B
| $1.24M | ﹤0.01% |
20,400
-1,000
| -5% | -$66.5K |
|
Similar funds
VI
FA
PBCM
CCAM
GBA
AWP
HI
DCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.